Sirona Biochem Initiates GlycoProteMim™ Trademark for Anti-Aging Molecule TFC-1326
VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF), is making a strategic move in the world of advanced skincare solutions. Today, the company announces the trademarking of its groundbreaking anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim™.
Related news for (SRBCF)
- Sirona Biochem Announces Debenture Financing
- Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
- Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report
- GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
- SIRONA BIOCHEM Corporate Update April 2024